- Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08
P. Wen, W. K. Alfred Yung, K. Lamborn, P. Dahia, Yan-Feng Wang, B. Peng, L. Abrey, J. Raizer, T. Cloughesy, K. Fink, M. Gilbert, S. Chang, L. Junck, D. Schiff, F. Lieberman, H. Fine, M. Mehta, H. Robins, L. DeAngelis, M. Groves, V. Puduvalli, V. Levin, C. Conrad, E. Maher, K. Aldape, M. Hayes, L. Letvak, M. Egorin, R. Capdeville, R. Kaplan, A. Murgo, C. Stiles, M. Prados
2006434 件引用Semantic Scholar
- Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.
K. Lamborn, W. K. Alfred Yung, Susan M. Chang, Patrick Y. Wen, T. Cloughesy, L. Deangelis, H. I. Robins, Frank Lieberman, Howard A. Fine, K. Fink, L. Junck, L. Abrey, M. Gilbert, M. Mehta, John G. Kuhn, K. Aldape, Janelle Hibberts, Pamela Peterson, M. Prados
2008408 件引用Semantic Scholar
- A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.
M. Prados, K. Lamborn, W. Yung, K. Jaeckle, H. I. Robins, M. Mehta, Howard A. Fine, P. Wen, T. Cloughesy, S. Chang, M. Nicholas, D. Schiff, H. Greenberg, L. Junck, K. Fink, K. Hess, J. Kuhn
2006234 件引用Semantic Scholar
- Team Learning: a Potential Solution To the Problems of Large Classes
L. Michaelsen, Warren E. Watson, J. P. Cragin, L. Fink
1982151 件引用Semantic Scholar
- Decreased Mortality of Severe Acute Pancreatitis After Proximal Cytokine Blockade
J. Norman, M. Franz, Gregory S. Fink, Jane L. Messina, P. Fabri, W. Gower, L. Carey
1995149 件引用Semantic Scholar